Anthem Inc (NYSE:ANTM) price target raised to $317.00 by Barclays

Analyst Ratings For Anthem Inc (NYSE:ANTM)

Story continues below

Today, Barclays raised its price target on Anthem Inc (NYSE:ANTM) to $317.00 per share.

There are 14 Buy Ratings, 2 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Anthem Inc (NYSE:ANTM) is Buy with a consensus target price of $325.2680 per share, a potential 28.39% upside.

Some recent analyst ratings include

  • 4/23/2019-Anthem Inc (NYSE:ANTM) has coverage initiated with a Buy rating and $294.00 price target
  • 4/21/2019-Anthem Inc (NYSE:ANTM) had its Buy rating reiterated by Cantor Fitzgerald with a $360.00 price target

    About Anthem Inc (NYSE:ANTM)
    Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2018, it served 40 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

    Recent Trading Activity for Anthem Inc (NYSE:ANTM)
    Shares of Anthem Inc closed the previous trading session at 253.42 up +2.23 0.89% with 249 shares trading hands.

    An ad to help with our costs